ABBVIEABBVIEABBVIE

ABBVIE

Không có giao dịch
Xem siêu biểu đồ

Trái phiếu 1ABBV

Sau đây là danh sách trái phiếu doanh nghiệp ABBVIE. Các nhà đầu tư thường lựa chọn trái phiếu của công ty vì tính ổn định cao hơn trong thời điểm thị trường biến động. Nghiên cứu giá cả, lợi suất và các số liệu thống kê khác và tìm khoản đầu tư đáng tin cậy.
Lợi suất đáo hạn %
Khối lượng
Giá %
Phiếu giảm giá %
Ngày đáo hạn
Giá trị dư nợ
Giá trị khuôn mặt
Giá trị mệnh giá tối thiểu
Bên phát hành
AACT4218879Allergan Funding SCS 3.8% 15-MAR-2025
73.69%12 K99.43%3.80%2025-03-15130.22 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
8.14%50 K74.10%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
7.69%15 K77.85%4.85%2044-06-1565.23 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
7.57%443 K99.97%3.80%2025-03-152.89 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
7.23%134 K79.81%4.63%2042-10-0167.49 M USD1,000.00 USD2,000.00 USDActavis, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
6.31%750 K89.19%4.55%2035-03-15107.65 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
6.06%5.21 M82.10%4.25%2049-11-215.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5.92%086.16%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5.84%089.47%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5.77%3.25 M88.01%4.40%2042-11-062.6 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5.77%20 K91.05%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5.74%26 K90.47%3.20%2029-11-2162.52 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5.73%4.38 M90.87%4.75%2045-03-15827.09 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5.73%994 K91.96%4.85%2044-06-151.01 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5.73%2.17 M86.62%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5.67%26.27 M97.96%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5.65%625 K97.20%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5.59%36 K91.45%4.63%2042-10-01389.22 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
5.57%5 M100.29%5.60%2055-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5.55%706 K98.12%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5.37%092.53%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5.27%094.88%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABCABBVIE 15/25
5.20%099.73%3.60%2025-05-143.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5.19%3.78 M95.78%4.55%2035-03-151.68 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
5.13%800 K100.44%5.20%2035-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
5.07%515 K99.91%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4.90%385 K93.52%3.20%2029-11-215.44 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4.79%160 K100.73%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
4.75%10.21 M100.53%4.88%2030-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4.61%65 K100.64%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4.53%1.02 M99.12%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
4.53%5.07 M100.33%4.65%2028-03-151.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4.50%098.55%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4.49%40 K97.58%2.95%2026-11-213.99 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4.41%330 K100.72%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XXS162262122ALLERGAN FNDG 17/29
4.07%093.01%2.13%2029-06-0136.46 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
XS190919331ALLERGAN FNDG 18/28
4.05%095.42%2.63%2028-11-1572.11 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
3.86%096.53%2.95%2026-11-219.24 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABGABBVIE 19/31
3.36%088.49%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
3.05%096.56%2.13%2029-06-01506.09 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
3.01%0102.15%3.80%2025-03-151.27 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS212591483ABBVIE 20/28
2.92%099.02%2.63%2028-11-15427.79 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
2.90%0121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS152090781ABBVIE 16/28
2.88%097.48%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
2.88%0126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2.83%0128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABEABBVIE 19/27
2.76%094.97%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2.35%0123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
3.80%2025-03-151,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.